Stephen K. Brannan insider trades
Open-market stock purchases and sales by Stephen K. Brannan, Director at Serina Therapeutics, Inc, from SEC Form 4 filings since Feb 14, 2020.
Open-market stock purchases and sales by Stephen K. Brannan, Director at Serina Therapeutics, Inc, from SEC Form 4 filings since Feb 14, 2020.